[Next-Generation Sequencing Book]
  • [Photo] J.W. Bizzaro • June 20, 2001
    ``It was to be a landmark university-corporate research partnership: Novartis, a Swiss-based pharmaceutical conglomerate, would pay $25 million over five years to the University of California at Berkeley.

    ``But what the company was to get in return shocked faculty, students, and outsiders alike.

    ``In exchange for funding, Novartis would be allowed to sift through the research of the department of plant and microbial biology at Berkeley's College of Natural Resources - licensing up to about one-third of the researchers' output.

    ``Students declared it a sellout. Legislators scheduled hearings. Professors protested the secrecy of the negotiations. One professor decried the deal for creating an `apartheid' of have and have-not faculty. Outside observers were no less impassioned.''

    Full story:
    http://www.csmonitor.com/durable/2001/06/19/fp11s1-csm.shtml

    Reference by Slashdot.org.

Discussion forums: Christian Science Monitor: Corporate Cash & Campus Labs

Expanded view | Monitor forum | Save place

Start a new thread:

You have to be logged in to post a reply.

© 1998-2025 Scilico, LLC. All rights reserved.